,PD-L1[F]FAPI[F]FDGPET/CT

Jingjie Qin1, Chao Han2,3, Haoqian Li1

  • 1Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No. 440 Jiyan Road, Jinan, Shandong, 250117, China.

概括

纤维细胞激活蛋白抑制剂 (FAPI) PET/CT与肺癌中编程死亡配体1 (PD-L1) 表达呈正相关性,这表明其在预测免疫治疗反应方面的潜力.